<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01231698</url>
  </required_header>
  <id_info>
    <org_study_id>2048</org_study_id>
    <nct_id>NCT01231698</nct_id>
  </id_info>
  <brief_title>Heart Rate Control With Esmolol in Septic Shock</brief_title>
  <official_title>Strict Heart Rate Control With Esmolol in Septic Shock: a Randomized, Controlled, Clinical Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Andrea Morelli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is investigate the effects on systemic hemodynamics and organ
      function of esmolol when used to maintain heart rate below a predefined threshold in patients
      with septic shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      154 septic shock patients with heart rate &gt; of 95 bpm and requiring vasopressor support to
      maintain mean arterial pressure between 65 and 75 mmHg despite adequate volume resuscitation,
      will be enrolled in the study. Patients will be randomly allocated to be treated with either
      a) a continuous esmolol infusion at any doses to maintain heart rate between 95 and 80 bpm
      b)to a standard treatment without heart rate control(control; each n = 77). In both groups,
      norepinephrine will be titrated to achieve a mean arterial pressure (MAP) between 65 and 75
      mmHg. Data from right heart catheterization,data from organ function as well as
      norepinephrine requirements will be obtained at baseline and after 24, 48, 72, and 96 hours.
      The protocol will require that esmolol be infused continuously at any doses to maintain the
      predefined heart rate threshold until one the following events occur: the patient die, a
      serious adverse effect attributed to the study drug infusion, or the patient has been
      discharged from ICU.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>heart rate</measure>
    <time_frame>over a period of 96 hrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>systemic hemodynamics</measure>
    <time_frame>over a period of 96 hours</time_frame>
    <description>systemic hemodynamics,norepinephrine requirements,organ functions,adverse effects.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>ICU Mortality</measure>
    <time_frame>28 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>esmolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>esmolol</intervention_name>
    <description>Strict heart rate control: esmolol at any dose to maintain heart rate between 95 and 80 bpm.</description>
    <arm_group_label>esmolol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>standard treatment without strict heart rate control</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  septic shock criteria

          -  presence of heart rate &gt; 95 bpm.

        Exclusion Criteria:

          -  Pregnancy

          -  age &lt; 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Morelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Roma La Sapienza</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive care of the University of Rome La Sapienza</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2010</study_first_submitted>
  <study_first_submitted_qc>October 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2010</study_first_posted>
  <last_update_submitted>January 23, 2013</last_update_submitted>
  <last_update_submitted_qc>January 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Andrea Morelli</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>esmolol</keyword>
  <keyword>tachycardia</keyword>
  <keyword>betablockers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esmolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

